Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 30;14(13):3215.
doi: 10.3390/cancers14133215.

Combining Molecular, Imaging, and Clinical Data Analysis for Predicting Cancer Prognosis

Affiliations
Review

Combining Molecular, Imaging, and Clinical Data Analysis for Predicting Cancer Prognosis

Barbara Lobato-Delgado et al. Cancers (Basel). .

Abstract

Cancer is one of the most detrimental diseases globally. Accordingly, the prognosis prediction of cancer patients has become a field of interest. In this review, we have gathered 43 state-of-the-art scientific papers published in the last 6 years that built cancer prognosis predictive models using multimodal data. We have defined the multimodality of data as four main types: clinical, anatomopathological, molecular, and medical imaging; and we have expanded on the information that each modality provides. The 43 studies were divided into three categories based on the modelling approach taken, and their characteristics were further discussed together with current issues and future trends. Research in this area has evolved from survival analysis through statistical modelling using mainly clinical and anatomopathological data to the prediction of cancer prognosis through a multi-faceted data-driven approach by the integration of complex, multimodal, and high-dimensional data containing multi-omics and medical imaging information and by applying Machine Learning and, more recently, Deep Learning techniques. This review concludes that cancer prognosis predictive multimodal models are capable of better stratifying patients, which can improve clinical management and contribute to the implementation of personalised medicine as well as provide new and valuable knowledge on cancer biology and its progression.

Keywords: Artificial Intelligence; cancer; data integration; machine learning; multimodal data; patient risk stratification; prognosis prediction; survival analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. International Agency for Research on Cancer Cancer Today: Data Visualization Tools for Exploring the Global Cancer Burden in 2018. [(accessed on 24 September 2020)]. Available online: Gco.iarc.fr.
    1. Wild C.P. The Global Cancer Burden: Necessity Is the Mother of Prevention. Nat. Rev. Cancer. 2019;19:123–124. doi: 10.1038/s41568-019-0110-3. - DOI - PubMed
    1. Loomans-Kropp H.A., Umar A. Cancer Prevention and Screening: The next Step in the Era of Precision Medicine. Npj Precis. Oncol. 2019;3:3. doi: 10.1038/s41698-018-0075-9. - DOI - PMC - PubMed
    1. Wild C.P., Espina C., Bauld L., Bonanni B., Brenner H., Brown K., Dillner J., Forman D., Kampman E., Nilbert M., et al. Cancer Prevention Europe. Mol. Oncol. 2019;13:528–534. doi: 10.1002/1878-0261.12455. - DOI - PMC - PubMed